LEIDEN, April 3, 2017 - BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), and Bethyl Laboratories, Inc. announced that they have signed an agreement allowing BIOKÉ to exclusively distribute Bethyl’s products in the BeNeLux countries, effective immediately.
Bethyl Laboratories is dedicated to supporting scientific discovery through its qualified polyclonal and recombinant rabbit monoclonal antibody products. Bethyl antibodies are manufactured to exacting standards and validated on-site in Montgomery, Texas. The company serves to advance science by concentrating its resources on developing qualified antibodies, including many to emerging and underserved protein targets.
Currently, Bethyl’s portfolio consists of over 7,150 catalog products; offering close to 5,700 primary antibodies targeting over 2,700 proteins and 1,450 secondary antibodies raised against immunoglobulins from over 25 species.
“The addition of Bethyl’s antibody products to the BIOKÉ portfolio strengthens our ability to provide a complete solution to customers in the Cell Biology and Functional Genomics field. Bethyl’s antibodies for emerging and underserved protein targets and the secondary antibodies against 25 species will advance the scientific discovery for many of our customers”, said Koos Kranenborg, Director of Marketing & Sales – BIOKÉ.
Founded in 2004 in Leiden The Netherlands, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe. BIOKÉ delivers unique and high-performance applications and workflows for genomics, protein analysis and cell biology. Since July 2009 BIOKÉ is the official EMEA base of operations for Cell Signaling Technology (CST), the market leader in the development of high quality antibody products and technologies. For additional information please visit the BIOKÉ website at www.bioke.com.
Bethyl Laboratories, Inc. improves lives by supporting scientific discovery through its quality antibody products and custom antibody services. Since its founding in 1972, Bethyl has manufactured all of its antibodies on-site to exacting standards with validation to a range of applications, including western blot, immunoprecipitation, immunohistochemistry, immunocytochemistry, ChIP, proximity ligation assay and ELISA. For additional information, please visit www.bethyl.com.